These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
636 related items for PubMed ID: 25731981
1. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities. Okamura S, Nishiyama E, Yamazaki T, Otsuka N, Taniguchi S, Ogawa W, Hatano T, Tsuchiya T, Kuroda T. Biochim Biophys Acta; 2015 Jun; 1850(6):1245-52. PubMed ID: 25731981 [Abstract] [Full Text] [Related]
2. [Search for Novel Antibacterial Compounds and Targets]. Kuroda T, Ogawa W. Yakugaku Zasshi; 2017 Jun; 137(4):383-388. PubMed ID: 28381710 [Abstract] [Full Text] [Related]
3. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors. Tiz DB, Skok Ž, Durcik M, Tomašič T, Mašič LP, Ilaš J, Zega A, Draskovits G, Révész T, Nyerges Á, Pál C, Cruz CD, Tammela P, Žigon D, Kikelj D, Zidar N. Eur J Med Chem; 2019 Apr 01; 167():269-290. PubMed ID: 30776691 [Abstract] [Full Text] [Related]
4. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus. Cheng J, Thanassi JA, Thoma CL, Bradbury BJ, Deshpande M, Pucci MJ. Antimicrob Agents Chemother; 2007 Jul 01; 51(7):2445-53. PubMed ID: 17502409 [Abstract] [Full Text] [Related]
5. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines. Werner MM, Patel BA, Talele TT, Ashby CR, Li Z, Zauhar RJ. Bioorg Med Chem; 2015 Sep 15; 23(18):6125-37. PubMed ID: 26320664 [Abstract] [Full Text] [Related]
6. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR. J Antimicrob Chemother; 2009 Dec 15; 64(6):1226-9. PubMed ID: 19833635 [Abstract] [Full Text] [Related]
7. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin. Sato M, Tanaka H, Oh-Uchi T, Fukai T, Etoh H, Yamaguchi R. Phytother Res; 2004 Nov 15; 18(11):906-10. PubMed ID: 15597305 [Abstract] [Full Text] [Related]
8. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z, Cao B, Liu YM, Gu L, Wang C. Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138 [Abstract] [Full Text] [Related]
9. [In vitro activity of daptomycin against VRE and MRSA strains]. Aktaş G, Derbentli S. Mikrobiyol Bul; 2014 Jan 05; 48(1):123-8. PubMed ID: 24506722 [Abstract] [Full Text] [Related]
10. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition. Ismail MMF, Abdulwahab HG, Nossier ES, El Menofy NG, Abdelkhalek BA. Bioorg Chem; 2020 Jan 05; 94():103437. PubMed ID: 31812260 [Abstract] [Full Text] [Related]
11. 6,6'-Dihydroxythiobinupharidine (DTBN) Purified from Nuphar lutea Leaves Is an Inhibitor of Protein Kinase C Catalytic Activity. Waidha K, Anto NP, Jayaram DR, Golan-Goldhirsh A, Rajendran S, Livneh E, Gopas J. Molecules; 2021 May 08; 26(9):. PubMed ID: 34066895 [Abstract] [Full Text] [Related]
12. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents. Hossion AM, Zamami Y, Kandahary RK, Tsuchiya T, Ogawa W, Iwado A, Sasaki K. J Med Chem; 2011 Jun 09; 54(11):3686-703. PubMed ID: 21534606 [Abstract] [Full Text] [Related]
13. Antibacterial activity of Australian plant extracts against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Palombo EA, Semple SJ. J Basic Microbiol; 2002 Jun 09; 42(6):444-8. PubMed ID: 12442307 [Abstract] [Full Text] [Related]
14. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus. Sharma M, Manhas RK. BMC Microbiol; 2019 Feb 19; 19(1):44. PubMed ID: 30782119 [Abstract] [Full Text] [Related]
15. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains. Pereira F, Madureira AM, Sancha S, Mulhovo S, Luo X, Duarte A, Ferreira MJ. J Ethnopharmacol; 2016 Feb 03; 178():180-7. PubMed ID: 26674158 [Abstract] [Full Text] [Related]
16. In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18-hACE2 Mice Infected with SARS-CoV-2. Weiss S, Waidha K, Rajendran S, Benharroch D, Khalilia J, Levy H, Bar-David E, Golan-Goldhirsh A, Gopas J, Ben-Shmuel A. Int J Mol Sci; 2023 May 05; 24(9):. PubMed ID: 37176034 [Abstract] [Full Text] [Related]
17. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Sakagami Y, Iinuma M, Piyasena KG, Dharmaratne HR. Phytomedicine; 2005 Mar 05; 12(3):203-8. PubMed ID: 15830842 [Abstract] [Full Text] [Related]
18. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents. Hossion AM, Otsuka N, Kandahary RK, Tsuchiya T, Ogawa W, Iwado A, Zamami Y, Sasaki K. Bioorg Med Chem Lett; 2010 Sep 01; 20(17):5349-52. PubMed ID: 20655215 [Abstract] [Full Text] [Related]
19. Antibacterial activity of stilbene oligomers against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics. Sakagami Y, Sawabe A, Komemushi S, All Z, Tanaka T, Iliya I, Iinuma M. Biocontrol Sci; 2007 Mar 01; 12(1):7-14. PubMed ID: 17408003 [Abstract] [Full Text] [Related]
20. Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains. Zidar N, Onali A, Peršolja P, Benedetto Tiz D, Dernovšek J, Skok Ž, Durcik M, Cotman AE, Hrast Rambaher M, Cruz CD, Tammela P, Senerovic L, Jovanovic M, Szili PÉ, Czikkely MS, Pál C, Zega A, Peterlin Mašič L, Ilaš J, Tomašič T, Kikelj D. Eur J Med Chem; 2024 Nov 15; 278():116823. PubMed ID: 39236496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]